Medical Condition: Respiratory Syncytial Virus (RSV)
Description: Respiratory Syncytial Virus, also called RSV, is a virus that commonly causes infections such as bronchiolitis (inflammation of the small airways in the lung) and pneumonia. While most will experience cold-like symptoms, it can lead to hospitalization for those with weak immune systems and chronic heart or lung disease. A research study is evaluating an investigational medication for the possible treatment of upper respiratory infections caused by RSV within the first 48 hours of symptoms. This research study may be an option if you:
- Have experienced symptoms of upper respiratory infection for no more than 48 hours – Symptoms may include the following: nasal discharge, nasal congestion, general discomfort/tiredness, headache, sinus congestion, sneezing, sore throat, hoarseness, cough, shortness of breath, respiratory wheeze, earache, fever and/or symptoms of fever
- Have not started taking any antiviral or antibacterial therapies
- Have tested positive for RSV infection and negative for Influenza (Research staff may conduct test to confirm infection as part of study qualification.)
- Do not have any other known respiratory infections other than RSV
Other criteria apply. Please make sure to discuss with a member of our research staff to ensure this research study is a good fit for you. Qualified participants will receive all study-related care and study medication or placebo at no cost.
Patient Commitment Duration: Approximately 2 weeks
Number of visits in study: Approximately 5 clinic visits
Patient Compensation: Financial compensation will be provided for time and travel expenses.
The team at WH Research can guide interested clinical research participants through the process of enrolling in a trial.
Please call 910-362-4040 between the hours of 8am-5pm for general research questions.